why choose us

First received: May 29, 2024

Clinical Trial: First Human Trial of Targeting MDM2/MDMX PET Imaging

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: MDM2/MDMX Gene Mutation

Study Type: INTERVENTIONAL


Official Title: First in Human Study on PET Imaging of Solid Tumors Using an MDM2/MDMX-Specific Probe

Brief Summary: Investigation of the Radiotracer Uptake of [68Ga] MDM2/MDMX Peptide at Lesion Sites in Patients with Malignant Tumors, and Evaluation of the Capability of [68Ga] MDM2/MDMX Peptide to Detect Overexpression of MDM2/MDMX in Tumor Patients, Particularly Those with Recurrent or Advanced Disease.

Read more